PROGYNOVA - Medsafe
PROGYNOVA® CMI 3 disease of the breasts (lumpy or painful breasts) or if you have first degree relatives (mother, sisters, daughters) who have had breast
Download PROGYNOVA - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Endocrinology Handbook Endocrine Unit Imperial College ...
imperialendo.co.uk1 Endocrinology Handbook Endocrine Unit Imperial College Healthcare NHS Trust Charing Cross, Hammersmith and St. Mary’s Hospitals Updated: March 2010
NNMAIN KD12 Thyroid Function - Normal and Abnormal.ppt ...
www.drketandhatariya.comA Bit of Endocrine Physiology •The Hypothalamic - Pituitary -Thyroid axis is a classic feedback loop
APPLICATION FOR ADDITIONAL DEPENDANTS - gemas.co.za
www.gemas.co.zaUniversal House 15 Tambach Road Sunninghill Park, Sandton Tel: 011 208 1000 Administered by: UNIVERSAL HEALTHCARE ADMINISTRATORS (PTY) LTD Reg. No. 1974/001443/07
PRODUCT INFORMATION ZYRTEC LEVOCABASTINE Eye …
www.medicines.org.auPage 2 of 7 February 2017 Pharmacokinetics After intranasal and ocular application, the absorption of levocabastine is incomplete with a systemic bioavailability ranging from 60 to 80% for the nasal spray and from 30 to 60% for the
DBL™ OCTREOTIDE INJECTION - Medsafe
www.medsafe.govt.nzData Sheet – New Zealand Version 4.0 1 DBL™ OCTREOTIDE INJECTION Name of medicine Octreotide acetate . Presentation . Each 1 mL vial of DBL™ Octreotide Injection is a clear colourless solution, containing 0.05 mg, 0.1 mg or
WHAT IS A WHAT ARE THE PROBLEMS …
www.neurosurgery.com.auHOW IS THIS DIAGNOSED ? Pituitary Stalk Anterior Lobe Posterior Lobe Pituitary Fossa Pituitary Third Ventricle Optic Nerve Carotid Artery Cranio-pharyngioma